Clinical significance of the expression of EGFR signaling pathway-related proteins in esophageal squamous cell carcinoma

PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells

(2013) Hao Liu et al.   BMC CANCER

Oesophageal carcinoma

(2013) Arjun Pennathur et al.   LANCET

Potential Therapeutic Significance of HER-Family in Esophageal Squamous Cell Carcinoma

(2012) Koji Kono et al.   Annals of Thoracic and Cardiovascular Surgery

Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia

(2012) Behnoush Abedi-Ardekani et al.   BMC CANCER

Adverse Prognostic Impact of Intratumor Heterogeneous HER2 Gene Amplification in Patients With Esophageal Adenocarcinoma

(2012) Harry H. Yoon et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeted Therapies with Chemoradiation in Esophageal Cancer: Development and Future Directions

(2012) Theodore S. Hong et al.   SEMINARS IN RADIATION ONCOLOGY

Multidisciplinary approach for patients with esophageal cancer

(2012) Victoria M Villaflor   WORLD JOURNAL OF GASTROENTEROLOGY

Enhanced phosphorylation of the epidermal growth factor receptor at the site of tyrosine 992 in esophageal carcinomas 

(2009) MICHIYO MIYAWAKI et al.   APMIS

Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment

(2009) Jaume Capdevila et al.   CANCER TREATMENT REVIEWS

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma

(2008) S Mahner et al.   BRITISH JOURNAL OF CANCER